Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region
- Written by PR Newswire
![]() |
MELBOURNE, Australia, Nov. 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed an exclusive agreement with Denmark-based WIIK Pharma ApS (Wiik Pharma) for the distribution of Telix's investigational prostate cancer imaging agent, Illuccix® (TLX591-CDx, Kit for the preparation...








